Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk, Saudi Arabia
Keywords:
olycystic ovary syndrome, Metabolic syndrome, Cardiovascular diseaseAbstract
Background: Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder at a reproductive age. It is associated with a high risk of metabolic syndrome (MS) and cardiovascular diseases (CVD).
Objective: To measure the prevalence of MS in women with PCOS and to assess the global cardiovascular risk (CVR) among them.
Methods: This cross-sectional study was conducted at King Khalid Hospital, Tabuk, Saudi Arabia during the period from February through December 2014. A total of 404 infertile women were randomly selected, and checked for diagnosing PCOS, MS and estimated CVD probability. Data were analyzed by IBM-SPSS version 22, using independent-samples t-test, Chi-square, and conditional logistic regression. A p-value of <0.05 was considered significant.
Results: MS was diagnosed in 58% and 32% of women with and without PCOS respectively (p<0.00). Results showed a statistically significant association between the two syndromes. Patients with the two syndromes showed high averages of clinical and biochemical values (p<0.00), high rate of predicted CVR, a high percentage of clustering of MS factors, and that weight-waist circumference - HDL are predictive for the occurrence of MS.
Conclusion: PCOS is associated with the risk of development of MS, and CVD. Screening for early detection of PCOS and MS and the application of cohort studies are recommended to better explore the role of PCOS in the development of CVD and to assess the significance of interventions.
References
Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007; 370(9588): 685- 97. doi: 10.1016/S0140-6736(07)61345-2.
March WA, Moore VM, Wilson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic
ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;
(2): 544-51. doi: 10.1093/humrep/dep399. PMID: 19910321.
Marcondes JAM, Barcellos CRG, Rocha MP. Dificuldades e armadilhas no diagnostico da syndrome dos
ovlriospolicysticos. Arq Bras Endocrinol Metab. 2011; 55(1): 6-15. doi: 10.1590/S0004- 27302011000100002.
Al-Ruhaily AD, Malabu UH, Sulimani RA. Hirsutism in Saudi females of reproductive age: a hospital- based study. Ann Saudi Med. 2008; 28(1): 28-32. doi: 10.4103/0256-4947.51762. PMID: 18299651.
Iftikhar S, Collazo-Clavell ML, Roger VL, St Sauver J, Brown RD Jr, Cha S, et al. Risk of cardiovascular
events in patients with polycystic ovary syndrome. Neth J Med. 2012; 70(2): 74-80. PMID: 22418753,
PMCID: PMC3582228.
Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose intolerance, type 2 diabetes and metabolic
syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update.
; 16(4): 347-63. doi: 10.1093/humupd/dmq001. PMID: 20159883.
Malik S, Wong ND. Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
Expert Rev Cardiovasc Ther. 2009; 7(3): 273-80. doi: 10.1586/14779072.7.3.273. PMID: 19296765.
Rouzi A, Ardawi M. Prevalence of the metabolic syndrome in Saudi women ad its components with
polycystic ovary syndrome. 8th European Congress on Menopause (EMAS). Maturitas. 2009;
(Supplement 1): S1–136.
Cobin RH. Cardiovascular and metabolic risks associated with PCOS. Intern Emerg Med. 2013; 8 (Suppl
: S61-4.
Scicchitano P, Dentamaro I, Carbonara R, Bulzis G, Dachille A, Caputo P, et al. Cardiovascular Risk in
Women with PCOS. Int J EndocrinolMetab. 2012; 10(4): 611-8. doi: 10.5812/ijem.4020. PMID: 23843832,
PMCID: PMC3693634.
Oliveira Rdo S, Redorat RG, Ziehe GH, Mansur VA, Conceição FL. Arterial hypertension and metabolic
profile in patients with polycystic ovary syndrome. Rev Bras Ginecol Obstet. 2013; 35(1):21-6. doi:
1590/S0100-72032013000100005. PMID: 23338549.
Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al. Women with polycystic
ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod.
; 28: 777-84. doi: 10.1093/humrep/des463. PMID: 23315061.
Wong ND, Pio JR, Franklin SS, L’Italien GJ, Kamath TV, Williams GR. Preventing coronary events by
optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol. 2003;
: 1421-26. doi: 10.1016/S0002-9149(03)00392-8.
Cussons AJ, Stuckey BGA, Watts GF. Cardiovascular disease in the polycystic ovary syndrome. new
insights and perspectives. Atherosclerosis. 2006; 185: 227-39. doi: 10.1016/j.atherosclerosis.2005.10.007.
PMID: 16313910.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on
diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril. 2004;
(1): 19-25. doi: 10.1016/j.fertnstert.2003.10.004.
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition: a consensus statement
from the International Diabetes Federation. Diabet Med. 2006; 23: 469–80. doi: 10.1111/j.1464- 5491.2006.01858.x. PMID: 16681555.
Risk Scoring Systems. 2013. Available from: http://www.framinghamheartstudy.org/.
Onaka L. Lipids. In Clinical Chemistry Concepts and Applications. London: W.B. Saunders; 1993.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein
cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502. PMID:
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and
management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood
Institute Scientific Statement. Circulation. 2005; 112: 2735–52. doi:
1161/CIRCULATIONAHA.105.169404. PMID: 16157765.
Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report.
Circulation. 2002; 106: 3143–421. PMID: 12485966.
Panidis D, Farmakiotis D, Rousso D, Katsikis I, Kourtis A, Diamanti-Kandarakis E. Serum
luteinizinghormone levels are markedly increased and significantly correlated with D4-androstenedione
levels in lean women with polycystic ovary syndrome. Fertil Steril. 2005; 84: 538-40. doi:
1016/j.fertnstert.2005.02.017. PMID: 16084906.
Spritzer PM. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
Arq Bras Endocrinol Metabol. 2014; 58(2): 182-7. doi: 10.1590/0004-2730000003051. PMID: 24830595.
de Vries L, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H. Endocrine effects of valproate in
adolescent girls with epilepsy. Epilepsia. 2007; 48: 470-7. doi: 10.1111/j.1528-1167.2006.00953.x. PMID:
Peppard HR, Marfori J, Iuorno MJ, Nestler JE. Prevalence of polycystic ovary syndrome among
premenopausal women with type 2 diabetes. Diabetes Care. 2001; 24: 1050-2. doi:
2337/diacare.24.6.1050. PMID: 11375369.
Moini A, Javanmard F, Eslami B, Aletaha N. Prevalence of metabolic syndrome in polycystic ovarian
syndrome women in a hospital of Tehran. Iran J Reprod Med. 2012; 10(2): 127-30.
Paul S, Smith L. The metabolic syndrome in women: a growing problem for cardiac risk. J Cardiovasc
Nurs. 2005; 20(6): 427–32. doi: 10.1097/00005082-200511000-00011.
Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review
and meta-analysis. Fertil Steril. 2011; 95: 1073-9.
Luo X, Xu L. Association of fat distribution with metabolic syndrome in patients with polycystic ovary
syndrome. Nan Fang Yi Ke Da Xue Xue Bao. 2012; 32: 1325‑7. PMID: 22985575.
Hudecova M, Jan H, Christian B, PoromaaInger S. Longterm Reproductive and Metabolic Consequences of
PCOS. Curr Diabetes Rev. 2012; 8: 444‑51. doi: 10.2174/157339912803529913. PMID: 22934549.
Al Mulhim AA, Abul Heija AA, Al Talib AA, Al Turki HA, Gasim TG. Hormonal, Metabolic and Clinical
Profile of Saudi Women with Polycystic Ovary Syndrome. Saudi Journal of Medicine & Medical Sciences.
; 1(1): 30-34. doi: 10.4103/1658-631X.112920.
Zachurzok Buczynska A, Szydlowski L, Gawlik A, Wilk K, Malecka‑Tendera E. Blood pressure regulation
and resting heart rate abnormalities in adolescent girls with polycystic ovary syndrome. Fertil Steril. 2011;
: 1519-23. doi: 10.1016/j.fertnstert.2011.09.043. PMID: 22032814.
Azevedo MF, Costa EC, Oliveira AI, Silva IB, Marinho JC, Rodrigues JA, et al. Elevated blood pressure in
women with polycystic ovary syndrome: Prevalence and associated risk factors. Rev Bras Gynecol Obstet
; 33: 31-6. PMID: 21625791.
Martins WdP, Soares GM, Vieira CS, Reis RMd, SáMFSd, Ferriani RA. Radiographic Assessment of
Maxillary Sinus Lateral Wall Thickness in Edentulous Posterior Maxilla. Revista Brasileira de Ginecologia
e Obstetrícia. 2009; 31:111-6. PMID: 19547885.
Li R, Yu G, Yang D, Li S, Lu S, Wu X, et al. Prevalence and predictors of metabolic abnormalities in
Chinese women with PCOS: a cross- sectional study. BMC Endocr Disord. 2014; 14: 76. doi:
1186/1472-6823-14-76. PMID: 25223276, PMCID: PMC4171713.
Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM. Who exceeds ATP-III risk thresholds? Systematic
examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. Prev
Med. 2008; 47: 619–23. doi: 10.1016/j.ypmed.2008.07.012. PMID: 18718484, PMCID: PMC2630457.
Marma AK, Lloyd-Jones DM. Systematic examination of the updated Framingham Heart Study general
cardiovascular risk profile. Circulation. 2009; 120: 384–90. doi:
1161/CIRCULATIONAHA.108.835470. PMID: 19620502.
Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime
risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006; 113: 791–8. doi:
1161/CIRCULATIONAHA.105.548206. PMID: 16461820.
Di Domenico K, Wiltgen D, Nickel FJ, Magalhães JA, Moraes RS, Spritzer PM. Cardiac autonomic
modulation in polycystic ovary syndrome: does the phenotype matter? Fertil Steril. 2013; 99(1): 286-92.
doi: 10.1016/j.fertnstert.2012.08.049. PMID: 23025880.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
